| Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1, 2-ethylenediamines M Protopopova, C Hanrahan, B Nikonenko, R Samala, P Chen, ... Journal of Antimicrobial Chemotherapy 56 (5), 968-974, 2005 | 518 | 2005 |
| Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug L Jia, JE Tomaszewski, C Hanrahan, L Coward, P Noker, G Gorman, ... British journal of pharmacology 144 (1), 80-87, 2005 | 328 | 2005 |
| Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults M Shah, C Hanrahan, ZY Wang, N Dendukuri, SD Lawn, CM Denkinger, ... Cochrane Database of Systematic Reviews, 2016 | 210 | 2016 |
| Body mass index and risk of tuberculosis and death CF Hanrahan, JE Golub, L Mohapi, N Tshabangu, T Modisenyane, ... Aids 24 (10), 1501-1508, 2010 | 185 | 2010 |
| Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ... Scientific reports 4 (1), 5658, 2014 | 152 | 2014 |
| Identification of New Diamine Scaffolds with Activity against Mycobacterium tuberculosis E Bogatcheva, C Hanrahan, B Nikonenko, R Samala, P Chen, J Gearhart, ... Journal of medicinal chemistry 49 (11), 3045-3048, 2006 | 152 | 2006 |
| Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa CF Hanrahan, K Selibas, CB Deery, H Dansey, K Clouse, J Bassett, ... PloS one 8 (6), e65421, 2013 | 119 | 2013 |
| Identification of SQ609 as a lead compound from a library of dipiperidines E Bogatcheva, C Hanrahan, B Nikonenko, G De los Santos, V Reddy, ... Bioorganic & medicinal chemistry letters 21 (18), 5353-5357, 2011 | 99 | 2011 |
| Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression CF Hanrahan, G Theron, J Bassett, K Dheda, L Scott, W Stevens, I Sanne, ... American journal of respiratory and critical care medicine 189 (11), 1426-1434, 2014 | 87 | 2014 |
| Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort T Omar, S Schwartz, C Hanrahan, T Modisenyane, N Tshabangu, ... Aids 25 (1), 87-94, 2011 | 78 | 2011 |
| Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States CK Lippincott, MB Miller, EB Popowitch, CF Hanrahan, A Van Rie Clinical infectious diseases 59 (2), 186-192, 2014 | 77 | 2014 |
| Implementation of Xpert MTB/RIF in Uganda: missed opportunities to improve diagnosis of tuberculosis CF Hanrahan, P Haguma, E Ochom, I Kinera, F Cobelens, A Cattamanchi, ... Open forum infectious diseases 3 (2), ofw068, 2016 | 69 | 2016 |
| Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study JR Ncayiyana, J Bassett, N West, D Westreich, E Musenge, M Emch, ... BMC infectious diseases 16, 1-10, 2016 | 66 | 2016 |
| Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa A Van Rie, L Page-Shipp, CF Hanrahan, K Schnippel, H Dansey, ... The International journal of tuberculosis and lung disease 17 (3), 368-372, 2013 | 60 | 2013 |
| Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB) CF Hanrahan, BAS Nonyane, L Mmolawa, NS West, T Siwelana, L Lebina, ... PLoS medicine 16 (4), e1002796, 2019 | 55 | 2019 |
| Higher cost of implementing Xpert® MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness E Hsiang, KM Little, P Haguma, CF Hanrahan, A Katamba, A Cattamanchi, ... The international journal of tuberculosis and lung disease 20 (9), 1212-1218, 2016 | 55 | 2016 |
| Mental health in South African adolescents living with HIV N West, S Schwartz, M Mudavanhu, C Hanrahan, H France, J Nel, ... AIDS care 31 (1), 117-124, 2019 | 54 | 2019 |
| Discovery of dipiperidines as new antitubercular agents E Bogatcheva, C Hanrahan, P Chen, J Gearhart, K Sacksteder, L Einck, ... Bioorganic & medicinal chemistry letters 20 (1), 201-205, 2010 | 53 | 2010 |
| Improving active case finding for tuberculosis in South Africa: informing innovative implementation approaches in the context of the Kharitode trial through formative research D Kerrigan, N West, C Tudor, CF Hanrahan, L Lebina, R Msandiwa, ... Health research policy and systems 15, 1-8, 2017 | 51 | 2017 |
| Risk factors for catastrophic costs associated with tuberculosis in rural South Africa N Stracker, C Hanrahan, L Mmolawa, B Nonyane, R Tampi, A Tucker, ... The International Journal of Tuberculosis and Lung Disease 23 (6), 756-763, 2019 | 45 | 2019 |
David DowdyProfessor of Epidemiology & Vice Dean for Education, Johns Hopkins Bloomberg School of Public Healthยืนยันอีเมลแล้วที่ jhsph.edu